emerg
sever
acut
respiratori
syndrom
sar
affect
global
health
caus
major
econom
disrupt
adequ
anim
model
requir
studi
underli
pathogenesi
sarsassoci
coronaviru
sarscov
infect
develop
effect
vaccin
therapeut
report
first
find
measur
clinic
diseas
nonhuman
primat
nhp
infect
sarscov
order
character
clinic
relev
paramet
sarscov
infect
nhp
infect
cynomolgu
macaqu
sarscov
three
group
group
infect
nare
bronchu
group
ii
nare
conjunctiva
group
iii
intraven
nonhuman
primat
group
ii
develop
mild
moder
symptomat
ill
nhp
demonstr
evid
viral
replic
develop
neutral
antibodi
chest
radiograph
sever
anim
group
ii
reveal
unifoc
multifoc
pneumonia
peak
day
postinfect
clinic
laboratori
test
significantli
chang
overal
inocul
mucos
rout
produc
promin
diseas
intraven
inocul
half
group
anim
infect
recombin
infecti
clone
sarscov
deriv
sarscov
urbani
strain
infecti
clone
produc
diseas
indistinguish
wildtyp
urbani
strain
late
chines
health
offici
report
unusu
number
atyp
pneumonia
case
guangdong
provinc
within
month
world
health
organ
alert
outbreak
widespread
throughout
provinc
march
ill
design
sever
acut
respiratori
syndrom
sar
spread
hong
kong
singapor
vietnam
toronto
canada
global
sar
outbreak
end
juli
exist
diseas
caus
fatal
signific
econom
impact
southeast
asia
special
concern
predilect
nosocomi
spread
sar
case
occur
healthcar
worker
certain
local
outbreak
hospit
staff
account
case
nosocomi
spread
patient
famili
member
account
signific
proport
sar
case
develop
adequ
anim
model
sar
high
research
prioriti
coronavirus
tend
limit
rang
host
speci
sever
anim
speci
found
support
sarsassoci
coronaviru
sarscov
replic
balbc
mice
shown
support
high
level
viral
replic
respiratori
tract
intranas
challeng
model
use
test
sar
vaccin
infect
addit
rodent
model
strain
mous
show
infect
respiratori
epithelium
intranas
sarscov
challeng
domest
cat
ferret
support
viral
replic
intratrach
challeng
ferret
model
use
studi
activ
passiv
immun
sar
research
focus
sever
anim
speci
potenti
natur
reservoir
sarscov
himalayan
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
found
suscept
infect
viru
close
relat
human
sarscov
experiment
infect
civet
produc
clinic
ill
histopatholog
evid
pneumonia
chicken
pig
challeng
sarscov
viral
rna
blood
first
week
postinfect
neither
speci
appear
support
signific
viral
replic
manifest
clinic
ill
recent
li
et
al
report
sever
speci
wild
bat
china
carrier
coronaviru
close
relat
sarscov
studi
evalu
anim
model
infect
pathogenesi
recombin
infecti
clone
sarscov
icsarscov
deriv
molecular
clone
nonhuman
primat
nhp
model
sarscov
infect
yield
absent
moder
observ
diseas
replic
sever
human
sar
fever
notabl
absent
studi
except
one
african
green
monkey
day
postinfect
studi
detect
sarscov
replic
one
sever
monkey
speci
document
seroconvers
therebi
confirm
establish
infect
asid
observ
clinic
symptom
studi
reli
viru
shed
histopatholog
specimen
necropsi
object
marker
diseas
studi
euthan
anim
cours
infect
document
histopatholog
diseas
two
studi
follow
anim
infect
studi
examin
radiograph
evid
pulmonari
diseas
one
promin
featur
sar
human
adult
human
sar
present
sever
febril
pneumonia
character
threephas
ill
first
phase
consist
flulik
ill
follow
phase
lower
respiratori
tract
diseas
third
phase
clinic
deterior
process
resembl
adult
respiratori
distress
syndrom
diseas
progress
somewhat
slow
onset
sever
respiratori
diseas
occur
anywher
wk
initi
symptom
pulmonari
radiograph
abnorm
almost
univers
report
sar
case
howev
earli
radiograph
may
normal
clear
evid
infect
without
radiograph
abnorm
small
number
case
multifoc
diseas
present
initi
radiograph
major
person
progress
multifoc
diseas
peak
symptom
onset
sever
diseas
develop
patient
ill
develop
diffus
confluent
airspac
consolid
consist
adult
respiratori
distress
syndrom
contrast
adult
sar
young
children
tend
rel
mild
diseas
adolesc
experi
signific
respiratori
diseas
similar
adult
younger
children
gener
constitut
symptom
myalgia
chill
headach
common
adult
usual
absent
children
children
shorter
cours
ill
afebril
gener
develop
pulmonari
diseas
signific
enough
requir
assist
ventil
even
supplement
oxygen
result
diagnost
criteria
reliabl
identifi
sar
pediatr
patient
expert
recommend
term
mild
acut
respiratori
syndrom
sarscov
infect
children
radiograph
find
children
sar
also
less
signific
adult
present
progress
children
normal
initi
chest
radiograph
children
abnorm
radiograph
unilater
focal
airspac
diseas
predomin
children
worsen
radiograph
diseas
ill
progress
multifoc
bilater
lung
involv
develop
case
radiograph
abnorm
children
gener
resolv
quickli
within
report
document
result
observ
studi
sarscov
icsarscov
infect
nonhuman
primat
studi
focus
clinic
virolog
paramet
associ
infect
cynomolgu
macaqu
attempt
examin
underli
mechan
diseas
studi
potenti
anim
model
sar
sarscov
urbani
strain
obtain
center
diseas
control
prevent
tom
ksiazek
atlanta
georgia
passag
four
time
vero
cell
american
type
cultur
collect
manassa
virginia
unit
state
inocul
final
prepar
sarscov
pb
use
infect
procedur
titer
plaqueform
unit
pfu
ml
sarscovspecif
antibodi
titer
determin
plaqu
reduct
neutral
test
prnt
day
infect
wk
postchalleng
prnt
perform
confluent
vero
cell
plate
describ
recombin
viru
icsarscov
use
passag
past
initi
transfect
deriv
molecular
clone
alreadi
report
icsarscov
prepar
titer
pfuml
eight
one
femal
seven
male
adult
cynomolgu
macaqu
macaca
fasciculari
weigh
kg
infect
see
sarscov
two
separ
iter
n
n
experi
anim
observ
daili
postinfect
six
anim
constitut
second
iter
addit
blood
drawn
day
postinfect
anim
anesthet
physic
examin
blood
drawn
preinfect
day
minu
everi
day
begin
day
infect
day
anesthesia
achiev
intramuscular
inject
telazol
mgkg
anesthet
anim
receiv
physic
examin
chest
radiograph
saphen
vein
blood
draw
swab
oral
nasal
rectal
mucosa
fece
collect
anim
cage
blood
draw
day
metabol
pan
stopvalv
drain
use
collect
urin
experi
conduct
biosafeti
laboratori
procedur
anim
room
personnel
wore
tyvek
suit
doubl
glove
power
airpurifi
respir
personnel
handl
viru
potenti
contamin
clinic
specimen
laboratori
use
class
ii
biolog
safeti
cabinet
wear
power
airpurifi
respir
research
conduct
complianc
anim
welfar
act
feder
statut
regul
relat
anim
experi
involv
anim
adher
principl
state
guid
care
use
laboratori
anim
research
conduct
facil
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
anim
infect
three
group
group
n
anim
inocul
nare
bronchu
inib
group
ii
n
nare
conjunctiva
incj
group
iii
n
intraven
iv
infect
carri
anesthesia
describ
two
anim
group
ii
infect
icsarscov
rest
anim
infect
wildtyp
viru
upright
anteriorposterior
ap
later
chest
radiograph
perform
anim
anesthesia
digit
radiograph
taken
minxray
hf
minxray
northbrook
illinoi
unit
state
portabl
xray
machin
radiograph
digit
process
fuji
fcr
smart
cr
reader
use
fuji
synaps
softwar
fujifilm
medic
system
usa
stamford
connecticut
unit
state
radiograph
read
boardcertifi
chest
radiologist
ml
blind
rout
infect
clinic
cours
anim
total
wbc
count
lymphocyt
count
absolut
percent
hemoglobin
hematocrit
platelet
count
red
cell
indic
measur
coulter
hematolog
analyz
beckman
coulter
fullerton
california
albumin
alkalin
phosphatas
alt
ast
amylas
bun
creatinin
total
bilirubin
total
protein
calcium
cholesterol
glucos
measur
vetscan
blood
chemistri
analyz
abaxi
union
citi
california
unit
state
two
realtim
revers
transcript
polymeras
chain
reaction
qpcr
assay
develop
detect
viral
rna
nhp
biosampl
tabl
assay
target
sarscov
gene
pol
smp
respect
detail
develop
test
sarscovspecif
qpcr
assay
tabl
found
protocol
rna
extract
nhp
biosampl
use
trizol
invitrogen
carlsbad
california
unit
state
accord
manufactur
recommend
purifi
rna
analyz
rugged
advanc
pathogen
identif
devic
rapid
idaho
technolog
salt
lake
citi
utah
unit
state
follow
rna
sampl
ad
appropri
sarsspecif
assay
master
mix
cycl
lightcycl
describ
protocol
test
run
includ
least
one
posit
control
contain
pfu
equival
plaquepurifi
sarscov
rna
two
notempl
control
reagent
sampl
quantifi
qpcr
result
report
pol
taqman
assay
viru
isol
attempt
select
biosampl
second
iter
six
anim
specimen
qpcr
cross
threshold
ct
less
ct
underw
cultur
viral
isol
briefli
media
swab
sampl
use
inocul
flask
vero
cell
atcc
flask
monitor
daili
cytopath
effect
viral
cultur
supernat
prepar
titer
use
viral
plaqu
assay
cell
scrape
pellet
fix
glutaraldehyd
millonig
phosphat
buffer
cell
pellet
wash
postfix
osmium
tetroxid
dehydr
embed
polyb
resin
polysci
warrington
pennsylvania
unit
state
ultrathin
section
stain
uranyl
acet
lead
citrat
examin
transmiss
electron
microscopi
virion
infect
eight
cynomolgu
macaqu
sarscov
three
group
group
n
infect
nare
bronchu
group
ii
n
nare
conjunctiva
group
iii
n
intraven
basic
clinic
find
summar
tabl
anim
group
ii
display
mild
moder
symptom
ill
begin
postinfect
day
pid
observ
symptom
includ
decreas
activ
decreas
feed
snuffl
mildli
labor
breath
anim
activ
appear
return
baselin
pid
case
anim
infect
wildtyp
sarscov
icsarscov
display
clinic
sign
ill
observ
overt
clinic
ill
group
iii
anim
infect
intraven
none
anim
develop
measur
fever
continu
telemetri
monitor
four
anim
reveal
signific
chang
temperatur
heart
rate
blood
pressur
left
ventricular
pressur
unpublish
data
chest
radiograph
result
avail
six
anim
three
exhibit
radiograph
evid
pulmonari
diseas
two
anim
infect
iv
rout
group
iii
signific
chang
chest
radiograph
three
four
anim
infect
mucos
rout
group
ii
develop
radiograph
diseas
figur
two
anim
radiograph
diseas
infect
icsarscov
group
one
anim
group
ii
infect
wildtyp
viru
three
anim
radiograph
evid
diseas
two
infect
ibin
rout
group
one
infect
cjin
rout
group
ii
develop
signific
airspac
diseas
pid
group
ii
anim
normal
radiograph
pid
develop
perihilar
left
upper
lobe
infiltr
pid
perihilar
diseas
right
upper
lobe
well
find
rel
subtl
began
resolv
pid
still
evid
albeit
continu
resolv
pid
two
group
anim
subtl
chang
pid
right
midlow
lobe
right
lower
lobe
radiograph
appear
unchang
pid
slight
increas
right
lower
lobe
opac
pid
anim
dramat
radiograph
chang
develop
increas
lower
lobe
diseas
new
rightupp
lobe
airspac
diseas
show
signific
increas
right
lower
lobe
consolid
increas
diseas
pid
demonstr
slight
improv
pid
chang
complet
resolv
pid
mild
residu
resolv
chang
still
evid
pid
blood
cell
count
reflect
minim
chang
infect
anim
demonstr
statist
signific
trend
rise
total
leukocyt
wbc
count
cours
infect
figur
mean
wbc
count
rose
per
liter
day
peak
per
liter
pid
p
twotail
pair
ttest
anim
wbc
count
usamriid
upper
limit
normal
per
liter
trend
wbc
count
observ
across
group
regardless
rout
exposur
absolut
percent
lymphocyt
follow
consist
trend
figur
sever
aberr
platelet
count
note
thought
secondari
clot
platelet
clump
overal
signific
chang
platelet
count
observ
group
abnorm
trend
note
hematolog
paramet
figur
alkalin
phosphatas
figur
becam
elev
two
group
anim
peak
unit
per
liter
usamriid
upper
limit
normal
ul
day
one
unit
per
liter
day
alkalin
phosphatas
elev
two
consecut
data
point
anim
return
normal
day
liverassoci
paramet
reflect
hepat
injuri
dysfunct
anim
figur
one
anim
group
isol
elev
alanin
aminotransferas
alt
unit
per
liter
usamriid
upper
limit
normal
ul
day
figur
alt
within
normal
rang
everi
day
anim
liverassoci
paramet
remain
within
normal
limit
cours
infect
serum
blood
urea
nitrogen
bun
creatinin
suggest
signific
chang
renal
function
anim
cours
sarscov
infect
figur
anim
convalesc
antisarscov
antibodi
detect
plaqu
reduct
neutral
test
prnt
perform
wk
postinfect
neutral
antibodi
undetect
baselin
anim
prnt
result
shown
tabl
group
anim
higher
titer
neutral
antibodi
comparison
geometr
mean
titer
group
analysi
varianc
show
statist
differ
viral
rna
detect
realtim
qpcr
biosampl
taken
anim
tabl
particular
viral
genom
nasal
swab
urin
detect
anim
regardless
rout
exposur
viremia
common
find
two
group
iii
infect
iv
anim
viru
detect
blood
shortli
inocul
would
expect
one
anim
detect
viremia
day
either
group
ii
one
anim
detect
viremia
posit
qpcr
pid
viru
shed
urin
univers
detect
earli
pid
late
pid
urinari
excret
viru
predominantli
late
phenomenon
shed
naso
pharynx
detect
anim
although
common
anim
challeng
mucos
rout
versu
intraven
rout
averag
number
day
versu
p
anova
one
anim
posit
nasal
swab
day
result
probabl
due
crosscontamin
time
collect
three
anim
prolong
persist
nasal
shed
inocul
mucos
rout
detect
viral
rna
rectal
fecal
specimen
vari
rout
infect
tabl
group
ii
anim
viral
genom
detect
least
five
contigu
rectal
swab
fecal
specimen
span
posit
specimen
averag
viral
rna
found
two
four
group
anim
undetect
group
iii
anim
p
anova
total
biosampl
qpcr
cross
threshold
five
anim
cultur
live
viru
isol
sampl
tabl
two
sampl
cross
threshold
one
neg
control
specimen
neg
cultur
result
wildtyp
infecti
clone
sarscov
isol
cultur
transmiss
electron
micrographi
posit
cell
cultur
reveal
spheric
virion
surfac
cell
well
matur
virion
bud
smoothwal
vesicl
consist
coronaviru
figur
studi
demonstr
cynomolgu
macaqu
infect
sarscov
develop
clinic
diseas
pulmonari
radiograph
find
presenc
radiograph
diseas
appear
depend
upon
rout
infect
four
anim
challeng
mucos
rout
group
ii
three
radiograph
evid
pulmonari
diseas
radiograph
diseas
develop
pid
peak
resolv
rapidli
neither
anim
intraven
challeng
group
group
iii
develop
radiograph
diseas
sarscov
replic
detect
varieti
site
infect
anim
viru
display
tropism
upper
respiratori
mucosa
replic
distal
site
reflect
system
viral
infect
data
human
studi
suggest
nasopharyng
shed
sarscov
increas
first
symptom
detect
consist
pattern
nasopharyng
shed
viremia
promin
featur
found
one
intraven
infect
anim
day
studi
frequenc
sourc
sarscov
genom
detect
correl
rout
inocul
anim
infect
intraven
group
iii
pauciti
posit
specimen
viruria
appear
day
persist
find
anim
tabl
anim
infect
mucos
group
ii
greater
number
posit
specimen
nasal
swab
throat
swab
two
group
ii
anim
posit
specimen
anim
signific
fecal
rectal
shed
presenc
degre
viral
shed
appear
correl
radiograph
diseas
group
ii
anim
develop
radiograph
diseas
extens
viral
shed
nasopharynx
urin
gastrointestin
tract
unusu
chang
hematolog
serum
chemistri
paramet
observ
figur
wbc
count
increas
significantli
remain
within
laboratori
normal
rang
unlik
experi
human
studi
nhp
detect
measur
chang
lymphocyt
platelet
count
renal
hepat
marker
suggest
signific
derang
cours
infect
although
alkalin
phosphatas
elev
briefli
two
anim
figur
explain
origin
transient
elev
alkalin
phosphatas
absenc
abnorm
liverassoci
enzym
brief
durat
abnorm
valu
make
signific
hepat
bone
injuri
unlik
diseas
produc
wildtyp
sarscov
urbani
icsarscov
clinic
indistinguish
observ
symptom
laboratori
paramet
vari
two
virus
icsarscovchalleng
anim
develop
radiograph
diseas
two
anim
infect
wildtyp
viru
mucos
rout
one
develop
radiograph
diseas
radiograph
find
rel
subtl
exclud
possibl
icsarscov
produc
signific
pulmonari
diseas
differ
find
like
relat
rout
infect
dose
anim
receiv
icsarscov
group
infect
bronchu
higher
dose
viru
importantli
fact
recombin
icsarscov
produc
diseas
clinic
similar
urbani
parent
support
hypothesi
molecular
clone
recapitul
diseas
phenotyp
macaqu
find
suggest
sarscov
sole
caus
sar
without
involv
coinfect
passeng
agent
model
use
icsarscov
may
pave
way
identif
genet
determin
pathogenesi
anim
seroconvert
convalesc
neutral
antibodi
detect
wk
infect
tabl
group
ii
higher
neutral
antibodi
titer
group
iii
differ
statist
signific
perhap
due
low
number
anim
involv
infect
appear
impart
protect
immun
least
short
term
six
anim
rechalleng
cj
inocul
sarscov
wk
initi
infect
six
display
clinic
sign
diseas
normal
chest
radiograph
unpublish
data
six
anim
includ
two
anim
initi
challeng
recombin
icsarscov
demonstr
molecularli
clone
viru
induc
protect
immun
respons
wildtyp
parent
studi
potenti
limit
observ
studi
design
achiev
statist
signific
paramet
measur
infect
small
number
anim
rout
may
observ
entir
spectrum
diseas
sever
order
ensur
viru
deliveri
lower
respiratori
mucosa
instil
larger
volum
viru
prepar
bronchoscop
group
anim
thu
group
receiv
total
inoculum
time
group
ii
five
time
group
iii
final
use
rel
high
inoculum
viru
although
infecti
dose
id
human
unknown
like
dose
administ
significantli
larger
use
high
inoculum
intent
produc
uniform
present
diseas
studi
anim
experi
offer
contrast
previous
publish
studi
sarscov
infect
nonhuman
primat
found
mild
moder
symptomat
diseas
cynomolgu
macaqu
infect
mucos
fouchier
et
al
kuiken
et
al
describ
signific
clinic
diseas
cynomolgu
macaqu
lethargi
rash
respiratori
distress
evid
anim
bukreyev
et
al
mcauliff
et
al
recount
overt
diseas
rhesu
cynomolgu
african
green
monkey
challeng
sarscov
urbani
report
higher
degre
viral
replic
african
green
one
african
green
monkey
also
note
singl
febril
temperatur
pid
day
row
et
al
examin
sarscov
infect
cynomolgu
rhesu
macaqu
report
minim
symptomat
diseas
row
et
al
studi
symptomat
infect
detect
anim
challeng
mucos
anim
infect
iv
evid
persist
viral
replic
upper
airway
vari
studi
row
et
al
report
spars
number
posit
nasal
oral
swab
although
one
posit
pid
contrast
combin
data
kuiken
et
al
fouchier
et
al
show
nasal
pharyng
shed
five
six
anim
mcauliff
et
al
detect
respiratori
tract
shed
infect
found
mucos
infect
anim
univers
shed
nasopharynx
pid
frequent
shed
pid
found
signific
persist
viru
presenc
urin
fece
well
studi
report
test
urin
viru
presenc
although
kuiken
et
al
report
viru
detect
pcr
necropsi
kidney
urinari
bladder
one
anim
mcauliff
et
al
found
posit
fecal
sampl
rtpcr
african
green
monkey
kuiken
et
al
row
et
al
test
rectal
swab
presenc
viru
found
none
posit
observ
differ
model
perform
difficult
explain
may
attribut
viral
strain
dose
rout
infect
bukreyev
et
al
mcauliff
et
al
also
use
urbani
strain
sar
cov
given
similar
rout
intranas
intratrach
clinic
observ
significantli
differ
use
differ
assay
method
total
dose
per
anim
probabl
higher
use
cell
cultur
infect
dose
also
refer
tcid
fouchier
et
al
kuiken
et
al
use
differ
strain
viru
isol
patient
observ
promin
clinic
symptom
despit
use
similar
dose
cell
cultur
infect
dose
administ
nare
trachea
row
et
al
use
dose
similar
pfu
sarscov
isol
canadian
patient
rout
deliveri
also
nare
trachea
radiograph
studi
present
much
clearer
pictur
pulmonari
diseas
previou
studi
use
nhp
kuiken
et
al
fouchier
et
al
pneumonia
evid
patholog
specimen
necropsi
pid
anim
follow
past
point
two
eight
anim
studi
row
et
al
patholog
evid
lung
diseas
necropsi
perform
postinfect
mcauliff
et
al
found
histopatholog
evid
viral
lung
infect
pid
resolv
pid
none
studi
use
object
method
measur
pulmonari
diseas
radiograph
appear
pneumonia
studi
may
afford
insight
nhp
model
sar
radiographi
provid
object
dynam
measur
pulmonari
diseas
radiograph
find
similar
radiograph
human
lesssever
case
sar
grow
evid
sar
may
present
mild
indol
diseas
adult
mild
diseas
adult
appear
except
howev
overal
experi
confirm
clinic
diseas
sarscov
infect
nhp
close
reproduc
sar
adult
human
similar
find
sar
children
deserv
examin
observ
unifoc
multifoc
radiograph
diseas
resolv
quickli
instead
progress
sever
diffus
diseas
consist
find
children
sar
absenc
fever
may
signific
would
seem
publish
report
children
sar
present
fever
data
bias
fever
univers
includ
case
definit
fever
children
less
ten
year
old
diagnos
sar
tend
rel
mild
short
durat
report
possibl
children
mild
clinic
ill
sar
develop
signific
fever
may
remain
undiagnos
premis
support
least
one
document
case
sar
adult
without
fever
hematolog
find
particularli
lymphopenia
preval
children
sar
macaqu
studi
row
et
al
find
lymphopenia
thrombocytopenia
anim
understand
differ
sar
adult
children
may
import
unravel
underli
pathogenesi
sar
adult
children
appear
similar
level
sarscov
viremia
associ
infect
impli
level
viral
replic
similar
group
adult
sar
significantli
increas
serum
level
inflammatori
cytokin
chemokin
activ
inflammatori
cytokin
children
sar
may
less
dramat
preliminari
data
suggest
case
nhp
well
thu
immun
respons
may
account
variat
sar
sever
age
group
even
speci
describ
experi
sarscov
infect
varieti
rout
cynomolgu
macaqu
wildtyp
sarscov
recombin
icsarscov
produc
similar
diseas
macaqu
model
prior
studi
found
overt
clinic
diseas
anim
infect
mucos
rout
much
less
sever
adult
human
sar
found
radiograph
pulmonari
diseas
anim
resembl
radiograph
find
human
sar
overal
diseas
observ
similar
sar
young
children
studi
need
determin
applic
nhp
model
studi
sar
